Gabapentin and Clonazepam Concomitant Use Safety
Concomitant prescribing of gabapentin with clonazepam is associated with increased risk of sedation and respiratory depression because both agents have CNS-depressant effects.[1] For older adults, benzodiazepines should generally be avoided, and additional CNS-active drugs increase falls and fracture risk.[2]
Core Recommendation
Avoiding the combination is recommended when clinically feasible due to additive CNS depression risk.[1][2] If the combination is clinically necessary, close monitoring for respiratory depression and excessive sedation is required.[1]
Medication Selection Algorithm
When both medications are under consideration, risk factors should be assessed first.[1]
- Respiratory impairment (COPD, baseline hypoventilation, significant sleep-disordered breathing) (high risk) should prompt avoidance or substantial caution.[1]
- Alcohol use and other CNS depressants (including opioids and sedative hypnotics) increase risk and should prompt avoidance of the combination.[1]
- Older age favors avoidance of benzodiazepines and reduction of CNS-active polypharmacy.[2]
Key Evidence Supporting This Recommendation
- FDA labeling for gabapentin reports associations with serious, life-threatening, or fatal respiratory depression when coadministered with CNS depressants, including opioids, and in patients with underlying respiratory impairment.[1]
- FDA safety communications for gabapentin describe serious breathing problems when gabapentin is used with CNS depressants and particularly in patients with respiratory disease or when other depressants are present.[3]
Monotherapy Versus Combination Therapy
- Benzodiazepine deprescribing and alternative non-benzodiazepine strategies reduce CNS-depressant burden and fall risk in older adults.[2]
- If seizure prophylaxis or anxiety indication requires ongoing clonazepam, gabapentin should be reconsidered for necessity and lowest effective dose because additive sedation risk is expected.[1][2]
Important Clarifications and Nuances
- The risk is amplified by other CNS depressants and by underlying respiratory impairment rather than by gabapentin dose alone.[1][3]
- Even in the absence of opioids, both agents contribute to sedation risk through CNS depression.[1]
- The presence of additional CNS-active drugs increases avoidance pressure in older adults.[2]
Initiation Thresholds or Indications
- The combination should generally be avoided in older adults because benzodiazepines are considered potentially inappropriate therapy and because CNS polypharmacy increases harm risk.[2]
- If used, initiation should occur only after a documented indication for each agent and documentation of absence of high-risk conditions (notably respiratory impairment, alcohol or additional CNS depressants).[1][3][2]
Common Pitfalls to Avoid
- Failure to account for additive CNS depression from multiple sedatives increases risk of serious outcomes.[1]
- In older adults, adding CNS-active agents to benzodiazepines contributes to CNS polypharmacy risk and increases falls and fractures.[2]
Target Blood Pressure
Not applicable.
Monitoring and Risk-Mitigation Measures
If the combination is prescribed, monitoring for excessive sedation and respiratory depression is indicated.[1] Avoidance of alcohol and additional sedatives should be ensured.[1]